RADT-26. IMPROVING RADIATION TARGET VOLUME DEFINITION FOR GLIOBLASTOMA USING PREDICTIONS OF TUMOR RECURRENCE FROM MACHINE LEARNING AND PRE-RADIOTHERAPY ADVANCED MRI
Nate Tran(University of California, San Francisco), Janine Lupo, Tracy Luks(University of California, San Francisco), Javier Villanueva‐Meyer(Baylor College of Medicine), Jennifer Clarke(Cornell University), Olivier Morin(University of California, San Francisco), Steve Braunstein(University of California, San Francisco), Susan Chang(University of San Francisco), Oluwaseun Adegbite(University of California, San Francisco), Jacob Ellison(University of California, San Francisco), Nicholas Butowski(University of California, San Francisco), Yan Li(Guiyang Medical University), Bo Liu(Central Hospital of Wuhan), Hui Lin, Devika Nair(University of California, San Francisco), Angela Jakary(University of California, San Francisco)
Cited by 1
Related Papers
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
|The Lancet Oncology|2017|1.1k
Estimating Survival in Patients With Lung Cancer and Brain Metastases
|JAMA Oncology|2016|655
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images
|Scientific Reports|2018|380
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
|Journal of Clinical Oncology|2008|377
Federated learning enables big data for rare cancer boundary detection
|Nature Communications|2022|364